2.80
0.00 (-0.18%)
| Penutupan Terdahulu | 2.80 |
| Buka | 2.83 |
| Jumlah Dagangan | 105,321 |
| Purata Dagangan (3B) | 294,401 |
| Modal Pasaran | 281,176,992 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.24 |
| Harga / Jualan (P/S) | 54.79 |
| Harga / Buku (P/B) | 3.60 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -184.04% |
| Margin Operasi (TTM) | -1,956.57% |
| EPS Cair (TTM) | -0.650 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -92.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.46% |
| Nisbah Semasa (MRQ) | 1.53 |
| Aliran Tunai Operasi (OCF TTM) | 46.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 57.57 M |
| Pulangan Atas Aset (ROA TTM) | -17.07% |
| Pulangan Atas Ekuiti (ROE TTM) | -43.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | AC Immune SA | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.63 |
|
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 38.01% |
| % Dimiliki oleh Institusi | 26.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bvf Inc/Il | 30 Sep 2025 | 19,822,436 |
| Julat 52 Minggu | ||
| Median | 8.00 (186.23%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 04 Nov 2025 | 8.00 (186.23%) | Beli | 3.30 |
| 08 Sep 2025 | 8.00 (186.23%) | Beli | 2.20 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |